Filing Details
- Accession Number:
- 0001415889-25-001014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-07 17:15:05
- Reporting Period:
- 2025-01-06
- Accepted Time:
- 2025-01-07 17:15:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468316 | Rosty Raykov | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2025-01-06 | 2,431 | $6.08 | 91,432 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2025-01-06 | 7,569 | $6.08 | 83,863 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
- Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020.
Billionaire Hedge Funds
